Russell Investments Group, Ltd. Macrogenics Inc Transaction History
Russell Investments Group, Ltd.
- $75.4 Billion
- Q2 2025
A detailed history of Russell Investments Group, Ltd. transactions in Macrogenics Inc stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 49,564 shares of MGNX stock, worth $72,859. This represents 0.0% of its overall portfolio holdings.
Number of Shares
49,564
Previous 1,614
2970.88%
Holding current value
$72,859
Previous $2,000
2850.0%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding MGNX
# of Institutions
116Shares Held
51.4MCall Options Held
45.1KPut Options Held
143K-
Bellevue Group Ag Kuesnacht, V89.93MShares$14.6 Million0.29% of portfolio
-
Armistice Capital, LLC New York, NY6.3MShares$9.26 Million0.12% of portfolio
-
Black Rock Inc. New York, NY5.4MShares$7.94 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.21MShares$6.19 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.25MShares$4.78 Million0.02% of portfolio
About MACROGENICS INC
- Ticker MGNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 61,458,800
- Market Cap $90.3M
- Description
- MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...